Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Meets Nasdaq Listing Requirement for $2.5M Stockholder Equity

Premium

Rosetta Genomics said this week that its shares will remain listed on the Nasdaq after the company regained compliance with the exchange's $2.5 million minimum stockholders' equity requirement.

The company still needs to comply with the Nasdaq's minimum $1 bid price requirement, and has until Aug. 8 to do so, it said.

"As a result of our recently announced private placement and concurrent registered offerings and the successful initial public offering in Israel of our majority-owned subsidiary Rosetta Green, we were successful in increasing stockholder equity beyond Nasdaq's listing requirement,” Rosetta President and CEO Kenneth Berlin said in a statement.